HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

P Kvasnicka Selected Research

2,5-dihydroxybenzylidene aminoguanidine

10/2003Influence of 2,5-dihydroxybenzylidene aminoguanidine on lipid oxidative damage and on antioxidant levels in model diabetes mellitus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


P Kvasnicka Research Topics

Disease

2Down Syndrome (Down's Syndrome)
01/2007 - 08/2001
2Diabetes Mellitus
10/2003 - 09/2000
1Heart Failure
07/2008
1Cardiac Sudden Death (Sudden Cardiac Arrest)
07/2008
1Carcinoma (Carcinomatosis)
11/2006

Drug/Important Bio-Agent (IBA)

2AntioxidantsIBA
10/2003 - 08/2001
1Atrial Natriuretic Factor (ANF)IBA
07/2008
1Biomarkers (Surrogate Marker)IBA
07/2008
1Troponin IIBA
07/2008
1Glutathione (Reduced Glutathione)IBA
01/2007
1Cisplatin (Platino)FDA LinkGeneric
11/2006
1LipidsIBA
10/2003
1Lipoproteins (Lipoprotein)IBA
10/2003
1pimagedine (aminoguanidine)IBA
10/2003
1Hypoglycemic Agents (Hypoglycemics)IBA
10/2003
12,5-dihydroxybenzylidene aminoguanidineIBA
10/2003
1EnzymesIBA
08/2001
1resorcylidene aminoguanidineIBA
09/2000